Yilong Wang | Drug Delivery Systems | Best Researcher Award

Posted on 31/01/202531/01/2025 by sciencefather

Yilong Wang | Drug Delivery Systems | Best Researcher Award

Prof Yilong Wang, Beijing Tiantan Hospital, Capital Medical University, China

Dr. Yilong Wang, Executive Vice President of Beijing Tiantan Hospital, Capital Medical University, is a distinguished neurologist and scientist. With an MD and PhD in Neurology, he has pioneered research in stroke and rare neurological disorders. Author of 301 impactful journal articles and holder of 12 patents, his innovative work spans drug delivery systems and precision medicine. Honored with the 2023 Paul Dudley White International Award, he has also authored several clinical neurology manuals. His cutting-edge contributions, including transcranial drug delivery devices, underscore his commitment to advancing global healthcare. 🌍📚

Publication Profile

google scholar

Academic and Professional Background

Professor Yilong Wang 🎓, an accomplished neurologist, earned his MBBS and MSc from North China University of Science and Technology, followed by an MD and PhD in Neurology from Capital Medical University. He completed postdoctoral training at the University of San Francisco 🌉. Currently serving as Executive Vice President and Chief Scientist at Beijing Tiantan Hospital 🏥, Prof. Wang has led groundbreaking research in stroke and rare neurological diseases 🧠. Over the past five years, he has published 72 high-impact papers 📄, holds 12 patents, and made significant strides in precision medicine and drug delivery systems 💊, earning prestigious accolades like the 2023 Paul Dudley White International Award 🏆.

Editorial Appointments

Professor Yilong Wang 🧑‍⚕️ holds prominent editorial roles, serving as the Assistant Editor-in-Chief of Stroke & Vascular Neurology 📚, Deputy Editor-in-Chief of the Chinese Journal of Cerebrovascular Diseases 🧠, and as an editorial board member of the Chinese Journal of Stroke ✍️. His collaborative efforts extend to leading institutions, including the Frontier Medical Interdisciplinary and Translational Center at the National Center for Neurological Disorders 🌐 and the Beijing Brain Science and Brain-Inspired Research Center 🧬. These partnerships underscore his commitment to advancing neurological research and fostering innovation in cerebrovascular and brain science 🏥.

Professional Memberships

Professor Yilong Wang 🧑‍⚕️ plays key leadership roles in various prestigious organizations. He serves as Vice Chairman of the Expert Committee for the National Health Commission’s Million Disability Reduction Project 🌟, demonstrating his dedication to public health. Prof. Wang is also the Deputy Leader of the Youth Group of the 8th Committee of the Neurology Branch of the Chinese Medical Association 🧠. Additionally, he is the Executive Vice Chairman of the Youth Working Committee of the Chinese Stroke Association 💼 and Vice Chairman of the Cerebral Small Vessel Disease Branch of the Chinese Stroke Association 🩺, driving innovation in neurological care.

Areas of Research

Professor Yilong Wang 🧑‍⚕️ specializes in clinical and translational research on cerebrovascular diseases and rare neurological disorders 🧠, with a focus on interdisciplinary medical-engineering innovations ⚙️. His research includes precision medicine for ischemic stroke 🩺, developing technologies for accurate diagnosis and treatment. He pioneers innovative drug delivery systems 💊, utilizing skull bone marrow-dura-lymphatic pathways to bypass the blood-brain barrier for safe intracranial drug delivery. Prof. Wang also investigates the pathogenesis, diagnostics, and interventions for cerebral small vessel disease and rare neurological disorders 🌐. Additionally, he advances intelligent skull flaps, smart drug delivery systems, and brain-computer interfaces 🤖.

Contributions

Professor Yilong Wang 🧑‍⚕️, a renowned neurologist at Beijing Tiantan Hospital 🏥, has revolutionized stroke and rare neurological disease research 🧠. Over the past five years, he has published 72 high-impact papers in top journals like NEJM, JAMA, and BMJ 📄 and holds 12 patents, with 2 successfully translated into clinical applications 🌟. His innovations include extending the time window for dual antiplatelet therapy, developing drugs for microcirculation disorders, and pioneering skull-based drug delivery systems to bypass the blood-brain barrier 💊. Recipient of the 2023 Paul Dudley White International Award 🏆, Prof. Wang has advanced precision medicine and rare disease research, improving global patient care 🌍.

Research Focus

Professor Yilong Wang is a distinguished researcher focusing on neurology, particularly stroke epidemiology, prevention, and management, and the application of artificial intelligence (AI) in healthcare. His work spans from analyzing stroke prevalence in China to exploring treatment strategies, including antiplatelet therapies and real-world applications of AI in medical practice. With a robust emphasis on stroke prevention, outcomes, and treatment innovation, his contributions bridge advanced research and clinical practice. Wang’s research also addresses the broader implications of healthcare technologies, underscoring their transformative potential. 🧠💊📊

Publication Top Notes

Artificial intelligence in healthcare: past, present and future

Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults

Clopidogrel with aspirin in acute minor stroke or transient ischemic attack

Stroke in China: advances and challenges in epidemiology, prevention, and management

Near-real-time monitoring of global CO₂ emissions reveals the effects of the COVID-19 pandemic

Rivaroxaban for stroke prevention after embolic stroke of undetermined source

Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese Intracranial Atherosclerosis (CICAS) Study

Summer soil drying exacerbated by earlier spring greening of northern vegetation

Ayaz Ahmed | Drug Discovery and Development | Best Researcher Award

Posted on 31/01/202531/01/2025 by sciencefather

Ayaz Ahmed | Drug Discovery and Development | Best Researcher Award

Dr Ayaz Ahmed, ICCBS – University of Karachi, Pakistan

Dr. Ayaz Ahmed 🧬🔬 is a Principal Investigator and Assistant Professor at the Dr. Panjwani Center for Molecular Medicine and Drug Research (PCMD), ICCBS, University of Karachi, Pakistan. With a Ph.D. in Biochemistry and Molecular Biology from Dalian Medical University, China, and an M.Sc. in Microbiology from the University of Karachi, his research focuses on microbial profiling, anti-biofilm agents, and infectious disease models. Dr. Ahmed has supervised numerous postgraduate students and received multiple international awards, including recognition from the American Society for Microbiology and Bill & Melinda Gates Foundation. He also leads funded projects on combating antibiotic-resistant pathogens. 🌟

Publication Profile

google scholar

Qualifications

Dr. Ayaz Ahmed holds a Ph.D. in Biochemistry and Molecular Biology from Dalian Medical University, China (2012), and a Master’s in Microbiology from the University of Karachi, Pakistan (2006, First Division). 🧬🎓 His doctoral research focused on the “Microbial profiling of dental plaque/Biofilm from dental caries and periodontitis patients” and explored the effects of Lactobacillus species on S. mutans biofilm formation. 🦷🔬 With a strong academic foundation and research expertise in microbiology and molecular biology, Dr. Ayaz contributes significantly to the understanding of microbial interactions in dental health and disease. 🌟

Job Responsibilities

Dr. Ayaz Ahmed is a Principal Investigator at the Cell Biology Lab, where he oversees the Imaging Facility, maintaining high-end fluorescence and light microscopes. He supports students by assisting them in acquiring high-quality images for their theses and manuscripts. Dr. Ahmed also manages the National Animal Facility for Laboratory Animal Research and Care. He supervises routine animal house operations and collaborates with a veterinary doctor to maintain SPF rats, mice, and hamsters. He is responsible for establishing models for infectious diseases and memory deficits to evaluate the efficacy of natural compounds. Dr. Ahmed also conducts toxicological studies and trains students in ethical animal research practices. 🧬🔬🐁

Student Supervised

Dr. Ayaz Ahmed and his team of dedicated researchers have made significant strides in their exploration of innovative therapeutic strategies. Among the Ph.D. candidates, Zulfiqar Ahmed’s research on controlling salmonellosis through probiotics in poultry, Binte Zehra’s study on modulating the metastatic potential of NSCLC, and Jazib Shafiq’s investigation into gut dysbiosis and anxiety have all been awarded. Additionally, Afshan Shams, Yamina Usmani, and Shariqa Khuwaja are examining the potential of natural and synthetic compounds in combating oral cancer and other diseases. Several M. Phil. students are also contributing to research on antimicrobial resistance and cancer therapies. 🧪🔬🧫

Honors and Awards

Dr. Ayaz Ahmed has earned numerous accolades throughout his distinguished career. In 2024, he received the Award for Collaborative Scientific Achievement from the Institute of Food Science and Technology, Chinese Academy of Agriculture Science, Beijing. He also became an International Federation for Biosafety Association (IFBA) Certified Biological Waste Management Professional and Bio-risk Management Professional in 2023. Dr. Ahmed was selected as a Mentor for the ASM Future Leaders Mentoring Fellowship Program in 2023 and was awarded the Health Security Partner Grant by the Bill & Melinda Gates Foundation in 2021. He has also earned prestigious travel awards and fellowships, including the American Society for Microbiology ID Fellowship and the Science and Technology Talent Award. 🏅🌍🦠

Completed Projects

Dr. Ayaz Ahmed has led multiple impactful research projects focused on combating multidrug-resistant microorganisms and improving public health. His research on the effect of synthetic and natural compounds on biofilm formation was funded by the Higher Education Commission of Pakistan (HEC) under project # HEC No: PD-IPFP/HRD/HEC/ 2013/1182. He also contributed to projects such as Personal Protective Equipment for Sindh Poultry Vaccine Center (funded by CRDF Global, USA), and oral pathogens related to dental caries (funded by ICCBS). Notably, his work on antimicrobial-resistant water contaminants, funded by the U.S.-Pakistan Centers for Advanced Studies in Water, aims to improve water quality. He further advanced research on antimicrobial and antibiofilm agents targeting Acinetobacter baumannii and Klebsiella pneumonia with funding from HEC. 💧🔬🦠

Professional Experience

Dr. Ayaz Ahmed has had a distinguished career in academia and research. Since June 2017, he has been serving as an Assistant Professor at the International Center for Chemical and Biological Sciences, University of Karachi. Prior to this, he worked as a Senior Research Officer at the same institution from November 2013 to June 2017. Dr. Ahmed also pursued Post-Doctoral training in Behavioral Sciences at Hunan Drug Safety Evaluation in Changsha, China, from January 2016 to February 2017. His earlier roles include Assistant Professor on Interim Placement, Research Officer in Avian Influenza Vaccine Production, and a research intern in the National Internship Program. 🧪📚

Professional Membership

Dr. Ayaz Ahmed is an active member of several prestigious professional organizations, contributing significantly to the fields of microbiology and infectious diseases. His memberships include the American Society for Microbiology (ASM) 🦠, the Pakistan Biological Safety Association (PBSA) 🧫, and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) 🌍. Additionally, he is a member of the American Association of Cancer Research (AACR) 🎗️ and the Medical Microbiology & Infectious Disease Society of Pakistan (MMIDSP) 🇵🇰. These memberships reflect his commitment to advancing research and innovation in microbiology, infectious diseases, and cancer research.

Research Focus

Dr. Ayaz Ayaz Ahmed research focus primarily revolves around microbiology, particularly in the fields of gut microbiota analysis, antimicrobial resistance, and biofilm formation. His studies often investigate the interactions between microorganisms and the human or animal host, such as comparing gut microbe profiles between healthy individuals and those with conditions like hyperthyroidism and liver cirrhosis. Additionally, Dr. Ahmed explores innovative therapeutic approaches, including the development of antimicrobial agents, such as nanoparticles conjugated with antibiotics to combat biofilm-forming pathogens like Klebsiella pneumoniae and Staphylococcus aureus. His work has significant implications for medical microbiology and the treatment of infectious diseases. 🦠🔬

Publication Top Notes

Gut microbe analysis between hyperthyroid and healthy individuals

Phylogenetic and biological characterization of Newcastle disease virus isolates from Pakistan

Bioﬁlm inhibitory effect of chlorhexidine conjugated gold nanoparticles against Klebsiella pneumoniae

Comparison of the gut microbe profiles and numbers between patients with liver cirrhosis and healthy individuals

Rifampicin conjugated silver nanoparticles: a new arena for development of antibiofilm potential against methicillin resistant Staphylococcus aureus and Klebsiella pneumoniae

Effect of Lactobacillus species on Streptococcus mutans biofilm formation.

Comparison of oral microbiota in orthodontic patients and healthy individuals

Synthesis and Chemosensing of Nitrofurazone using Olive oil based Silver Nanoparticles (O-AgNPs)

Isolation of dihydrobenzofuran derivatives from ethnomedicinal species Polygonum barbatum as anticancer compounds

Sajid Ali | Nanomedicine | Excellence in Research

Posted on 29/01/202529/01/2025 by sciencefather

Sajid Ali | Nanomedicine | Excellence in Research

Dr Sajid Ali, Quaid I azam university Islamabad, Pakistan

Dr. Sajid Ali, a dedicated pharmacist from Pakistan, holds a PharmD (CGPA 3.8/4) and an MPhil in Pharmaceutics (CGPA 3.9) from Quaid-i-Azam University, Islamabad. With experience as a lab demonstrator and pharmacist, he excels in pharmaceutical sciences, including HPLC, UV spectroscopy, and GMP implementation. Dr. Ali’s research on green-synthesized zinc oxide nanoparticles for wound management was published in Microbial Pathogenesis. Passionate about global healthcare, he has also completed numerous certifications, including antimicrobial resistance and pharmaceutical innovations. Dr. Ali’s multilingual abilities, extracurricular contributions, and drive for innovation position him as a transformative force in healthcare. 💊🌍

Education

Dr. Sajid Ali is currently pursuing an MPhil in Pharmaceutics at Quaid-i-Azam University, Islamabad 🏛️, a prestigious institution known for its excellence in research and education 🌟. He began this advanced academic journey on September 1, 2023, and continues to deepen his expertise in the field of pharmaceutics 💊. Previously, Dr. Sajid completed his Doctor of Pharmacy (Pharm.D) degree at the same university 🎓, spanning from September 2018 to September 2023. With a strong foundation in pharmacy and a passion for innovation in healthcare 🌱, Dr. Sajid aspires to make significant contributions to the pharmaceutical sciences. 🌟

Work Experience

Dr. Sajid Ali, a dedicated pharmacist from Pakistan 🎓🇵🇰, has a robust professional journey spanning academia, community pharmacy, and industry. As a Lab Demonstrator at Quaid-i-Azam University (Sept 2024–Mar 2025) 📚🧪, he guided students in using advanced pharmaceutical instruments like HPLC and FTIR while honing their analytical skills. Currently, as a Pharmacist at Al Shifa Pharmacy in Rawalpindi (Sept 2024–Present) 💊👩‍⚕️, he ensures accurate medication dispensing, patient counseling, and inventory management. His prior role as an Industrial Pharmacist at Glitz Pharmaceutical (July–Aug 2023) 🏭🔬 focused on R&D, quality control, and GMP compliance. Sajid’s journey began at Siddique Homeo Clinic (2018–2022) 🌿🤝, where he excelled in patient counseling and multitasking.

Online Courses

Dr. Sajid Ali has an impressive record of completing various online courses, showcasing his dedication to continuous learning 🌟. He gained expertise in International Business through a course at the University of New Mexico, covering exporting goods, joint ventures, and branch distribution 🌍. During the pandemic, he enriched his knowledge with COVID-19 – A Clinical Update from the University of Florida 🦠. Dr. Ali also explored Cancer Biology at Johns Hopkins University 🔬, clinical terminology at the University of Pittsburgh 🏥, and Pharmaceutical Innovations at the University of Minnesota 💊. Additionally, he completed an Antimicrobial Resistance course at the Technical University of Denmark 🧪.

Volunteer Experience

Dr. Sajid Ali has been actively contributing to the Pakistan Polio Eradication Programme under WHO, conducting numerous Lot Quality Assurance Sampling (LQAS) during the August 2023 National Immunization Day (NID) campaign 📊. He collected vital household data through handheld devices in targeted areas of Rawalpindi, ensuring data accuracy and quality 🔍. Additionally, Dr. Sajid received a prestigious certificate in Quality Considerations for Aseptic Processing from the United States Pharmacopoeia Education in December 2022 🧪. He also earned a certificate for participating in the Chinese Bridge: Travel with Tang Poetry online program, fostering cross-cultural learning, sponsored by China’s Ministry of Education 🌏📜.

Research Focus

Dr. Sajid Ali focuses on nanotechnology in biomedical applications, particularly in developing green-synthesized nanoparticles for wound management. His research bridges nanotechnology 🧪, drug delivery systems 💊, and antimicrobial therapies 🦠 to improve healing processes 🩹. By utilizing environmentally friendly methods 🌱, Dr. Ali innovates solutions for antibiotic delivery and enhanced tissue repair. His work contributes to sustainable medical technologies, showcasing a dual impact on infection control and wound care. Dr. Ali’s groundbreaking research highlights the intersection of nanomedicine and green chemistry, fostering advancements in healthcare innovation 🚑.

Publication Top Notes

Harnessing Green Synthesized Zinc Oxide Nanoparticles for Dual Action in Wound Management: Antibiotic Delivery and Healing Promotion

Claudia Omes | Clinical Trials | Best Researcher Award

Posted on 29/01/202529/01/2025 by sciencefather

Claudia Omes | Clinical Trials | Best Researcher Award

Dr Claudia Omes, Fondazione IRCCS Policlinico San Matteo, Italy

Dr. Claudia Omes is a distinguished biologist specializing in reproductive medicine, embryology, and stem cell research. She holds multiple degrees from the University of Pavia and Milan, including a Ph.D. in Bioengineering and Bioinformatics. Dr. Omes is the Head Biologist and Lab Director at the Center for Reproductive Medicine at Policlinico “San Matteo,” Pavia, and a Contract Professor at the University of Pavia. She has contributed to pioneering research in cryopreservation, semen analysis, and stem cell biology, with multiple publications in top journals. She is an active member of ESHRE and SIERR. 🧬🔬👩‍🔬📚

Publication Profile

Orcid

Qualifications and Certifications

Dr. Claudia Omes is a distinguished expert in bioengineering and bioinformatics, holding a Ph.D. in the field, along with a Postgraduate degree in Microbiology and Virology, both achieved with high honors 🎓. She also holds multiple specialized certifications, including ISO 9001:2008 Certified Auditor in Public Health 🏅 and certifications in clinical embryology and semen analysis 🧬. Her expertise spans across bioengineering, public health, and clinical research, making her a prominent figure in the scientific community. Dr. Omes’ comprehensive academic background and specialized certifications highlight her commitment to advancing healthcare and biotechnology. 🌿💡

Research Experience

Dr. Claudia Omes is the Head Biologist and Lab Director at the Center for Reproductive Medicine of Fondazione I.R.C.C.S. Policlinico “San Matteo.” Her pioneering work in human reproduction and embryology has significantly advanced the field. She specializes in cryopreservation of spermatozoa, oocytes, and embryos, as well as in stem cell research and bone tissue engineering. Through her dedication and expertise, Dr. Omes has made notable contributions to reproductive medicine, with a focus on improving fertility treatments and tissue regeneration. Her work continues to shape the future of reproductive science. 🧬🔬🍼👩‍🔬

Awards and Recognition

Dr. Claudia Omes has earned significant recognition in the scientific community. She was awarded the Best Oral Communication in the Biological Field at the II FISSR conference in Riccione (May 24-26, 2012) 🏅. In 2011, she received the GIC Study Award from the Italian Society of Cytometry at the XXIX National Conference of Cytometry in Salerno 🎖️. Dr. Omes was also honored with the Best Poster award at the 62nd National Congress of SIAI in Verona (September 14-16, 2008) 🎨. These accomplishments showcase her excellence in the fields of cytometry and biological sciences 🌱🔬.

Research Focus

Dr. Claudia Omes focuses on reproductive biology and male infertility, exploring factors that impact sperm quality and fertility. Her research investigates the role of infections, inflammation, and biomarkers in male fertility, particularly in infertile and oncological patients. She has contributed to studies on the effects of HPV infections (HPV-51 and HPV-52) on sperm quality, the expression of miRNAs in pre-implantation embryos, and the potential of novel diagnostic approaches like calprotectin to screen for male infertility risk. Additionally, Dr. Omes has studied the effects of cancer-induced inflammation on semen quality and the application of stem cells in reproductive medicine. 🧬👨‍🔬💉

Publication Top Notes

HPV-51 or HPV-52 Infection Could Impair Sperm Quality in Infertile Patients: A Preliminary Study on Our Experience from North-Western Italy

Expression of miRNA from spent pre-implantation embryos culture media

Human Ovarian Follicular Fluid Mesenchymal Stem Cells Express Osteogenic Markers When Cultured on Bioglass 58S-Coated Titanium Scaffolds

Calprotectin as a novel diagnostic approach to screen male infertility risk: A pilot study

Male fertility preservation: is there a role for cancer-induced inflammation that affects semen quality in oncological patients?

Myeloperoxidase and lactoferrin as possible inflammatory markers of an infertility risk?

Correction: MAGIC-factor 1, a partial agonist of MET, induces muscle hypertrophy by protecting myogenic progenitors from apoptosis (PLoS ONE (2008) 3:9 (e3223) 10.1371/journal.pone.0003223)

Amedea B. Seabra | Pharmaceutical Chemistry | Excellence in Research

Posted on 29/01/202529/01/2025 by sciencefather

Amedea B. Seabra | Pharmaceutical Chemistry | Excellence in Research

Assoc. Prof. Dr Amedea B. Seabra, Universidade Federal do ABC, Brazil

Assoc. Prof. Dr. Amedea B. Seabra is a renowned researcher in Chemistry at Universidade Federal do ABC (UFABC), Brazil. With a Ph.D. from UNICAMP, she specializes in biomaterials, nitric oxide release, and drug delivery systems. Her research includes developing novel materials for medical applications, such as nitric oxide-releasing hydrogels and vascular prostheses. Dr. Seabra has contributed significantly to projects related to wound healing and cardiovascular health. She has received numerous accolades, including recognition in global scientific databases and awards for her work on antimicrobial silver nanoparticles. 🌟🔬💉📚🌍

Publication Profile

Google Scholar

Academic Excellence

Assoc. Prof. Dr. Amedea B. Seabra holds a PhD in Chemistry from Universidade Estadual de Campinas (UNICAMP) and completed postdoctoral research at Concordia University and UNICAMP. Specializing in the controlled release of drugs, biomaterials, and nitric oxide chemistry, she has made significant contributions to both basic and applied sciences. Dr. Seabra’s work bridges the gap between research and practical applications, particularly in advancing drug delivery systems and exploring innovative biomaterials. Her research continues to have a profound impact on the development of therapeutic strategies for various medical challenges. 🧪💊🔬🌍

Professional Engagement

Assoc. Prof. Dr. Amedea B. Seabra is a distinguished academic with a wealth of experience in the field of biotechnology. Currently, she serves as the Vice Coordinator at the UFABC Graduate Program in Biotechnology and works as a collaborative researcher at the University of Edinburgh. Dr. Seabra has actively contributed to various international projects, including the prestigious Newton Advanced Fellowship. Her dedication to advancing research and fostering global collaborations highlights her commitment to scientific progress. 🌍🔬👩‍🔬💡

Awards and Recognition

Assoc. Prof. Dr. Amedea has made remarkable contributions to the scientific community, earning widespread recognition for her work. She was included in the prestigious Top 100,000 Scientists by C-Score and named among the most influential scientists globally in 2023 by Elsevier and Stanford University. Her exceptional achievements reflect her dedication and impact in her field. 🌍🔬📚🌟 Her ongoing research continues to inspire and drive advancements, solidifying her place as a leading figure in the scientific world. 👩‍🔬✨

Research Focus

Assoc. Prof. Dr. Amedea B. Seabra’s research focuses on nanotechnology, particularly the toxicology and antimicrobial properties of nanoparticles. Her studies investigate the synthesis, characterization, and biological effects of metal nanoparticles, such as silver and copper, including their cytotoxicity, genotoxicity, and environmental hazards. She has explored the potential of biogenically synthesized nanoparticles and their application in medicine, such as antimicrobial activity and toxicity in model organisms. Her work extends to the use of cellulose nanocrystals in medicine and addresses the risks posed by metal oxide nanoparticles. Overall, her research contributes to the safe application of nanomaterials. 🧬🧪⚛️

Publication Top Notes

Silver nanoparticles: A new view on mechanistic aspects on antimicrobial activity

Nanotoxicity of graphene and graphene oxide

Silver nanoparticles: a brief review of cytotoxicity and genotoxicity of chemically and biogenically synthesized nanoparticles

Green tea extract mediated biogenic synthesis of silver nanoparticles: Characterization, cytotoxicity evaluation and antibacterial activity

In vitro antifungal efficacy of copper nanoparticles against selected crop pathogenic fungi

Silver nanoparticles: Toxicity in model organisms as an overview of its hazard for human health and the environment

S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance

Antimicrobial activity of biogenic silver nanoparticles, and silver chloride nanoparticles: an overview and comments

Biogenic nanoparticles: copper, copper oxides, copper sulphides, complex copper nanostructures and their applications

Thermal and photochemical nitric oxide release from S-nitrosothiols incorporated in Pluronic F127 gel: potential uses for local and controlled nitric oxide release

Ali Olad | Drug Delivery Systems | Best Researcher Award

Posted on 28/01/202528/01/2025 by sciencefather

Ali Olad | Drug Delivery Systems | Best Researcher Award

Prof Ali Olad, University of Tabriz, Iran

Prof. Ali Olad is a distinguished researcher in applied chemistry, specializing in polymer composites, conducting polymers, and polymeric coatings. 🎓 He earned his Ph.D. in Applied Chemistry (2003) from the University of Tabriz, where he continues to teach courses on industrial chemistry, polymer nanocomposites, and coatings. 📚 His research focuses on nanocomposites, conducting polymers, corrosion resistance, and environmental pollutant detection. 🌱🧪 Prof. Olad has presented groundbreaking work globally, authored influential books, published high-impact papers, and holds patents on polyaniline nanostructures and advanced materials. 🏆💡 His innovations in hydrogels, fertilizers, and sensors reflect his commitment to sustainable and practical chemical solutions. 🌍✨

Publication Profile

Google Scholar

Educational Background

Prof. Ali Olad is a distinguished academic specializing in Applied Chemistry, with a focus on polymer composites, conducting polymers, and corrosion-resistant polymeric coatings. 🎓 He earned his Ph.D. in Applied Chemistry (Polymer Composites & Conducting Polymers) from the University of Tabriz, Iran, in 2003. 📘 Prior to this, he completed his M.Sc. in Applied Chemistry (Corrosion & Polymeric Coatings) in 1997 and his B.Sc. in Applied Chemistry in 1995, both from the same institution. 🔬 His expertise and academic achievements contribute significantly to advancements in materials science, fostering innovative research and practical applications in the field. 🌟

Experience

Prof. Ali Olad has a remarkable teaching career at the University of Tabriz, offering diverse courses across various academic levels. He has taught Conducting Polymers at the Ph.D. level (2006–2010) and Industrial Chemistry 2 at the B.Sc. level since 1997. Additionally, he lectured on Industrial Electrochemistry (2003–2017). Prof. Olad continues to teach Coatings and Adhesives (Ph.D.), Polymer Composites and Nanocomposites (M.Sc.), and Physical and Mechanical Properties of Polymers (M.Sc.) since 2010. His dedication to education and expertise in polymers, nanocomposites, and industrial chemistry have greatly contributed to the field. 🎓📚🧪✨

Research Interests

Prof. Ali Olad specializes in the fields of polymer composites and nanocomposites, focusing on their development and applications. His expertise extends to surface modification and polymer coatings, enhancing material performance. Additionally, he works on conducting polymers and blends, exploring their conductive properties. Prof. Olad’s research also delves into polymer hydrogels, investigating their potential in various biomedical and industrial applications. Furthermore, he studies corrosion and electrochemistry, aiming to improve material durability and sustainability. His contributions to these areas have led to advancements in materials science and engineering. 🌐🔬🧪💡🛠️

Research Focus

The individual behind these publications appears to have a research focus in materials science, environmental engineering, and nanocomposites, with particular attention to polymers, hydrogel systems, and waste treatment technologies. Their work spans a range of topics such as electrocoagulation for dye removal, slow-release fertilizers, and anti-corrosion coatings, with an emphasis on nanocomposite materials like clay-polymers, superabsorbent hydrogels, and conductive polymers. This person is also involved in environmental cleanup and water treatment, exploring methods to improve water quality by utilizing advanced materials and nanotechnology 🧪🌍💧🔬.

Publication Top Notes

Decolorization of basic dye solutions by electrocoagulation: An investigation of the effect of operational parameters

Slow-released NPK fertilizer encapsulated by NaAlg-g-poly (AA-co-AAm)/MMT superabsorbent nanocomposite

Anti-corrosive properties of polyaniline coating on iron

Slow-release NPK fertilizer encapsulated by carboxymethyl cellulose-based nanocomposite with the function of water retention in soil

Polymer-clay nanocomposites

Superabsorbent hydrogel made of NaAlg-g-poly (AA-co-AAm) and rice husk ash: Synthesis, characterization, and swelling kinetic studies

On the preparation and swelling properties of hydrogel nanocomposite based on Sodium alginate-g-Poly (acrylic acid-co-acrylamide)/Clinoptilolite and its …

Removal of chromium from aqueous solution using polyaniline–poly ethylene glycol composite

Optimization of electrocoagulation process for removal of an azo dye using response surface methodology and investigation on the occurrence of destructive side reactions

Preparation and anticorrosive properties of PANI/Na-MMT and PANI/O-MMT nanocomposites

The synergetic effect of bioactive ceramic and nanoclay on the properties of chitosan–gelatin/nanohydroxyapatite–montmorillonite scaffold for bone tissue engineering

Dipanjan Karati | Drug Discovery and Development | Best Researcher Award

Posted on 28/01/202528/01/2025 by sciencefather

Dipanjan Karati | Drug Discovery and Development | Best Researcher Award

Dr Dipanjan Karati, Techno India University, West Bengal, India

Dr. Dipanjan Karati is an Assistant Professor at Techno India University, West Bengal, with expertise in pharmaceutical chemistry. He holds a M. Pharm (2021) from Bharati Vidyapeeth University and a B. Pharm (2019) from MAKAUT, both with distinction. His research focuses on neurodegenerative diseases and antimicrobial agents, with several publications in prestigious journals. Dr. Karati has actively participated in numerous seminars, webinars, and workshops. He is a GPAT 2019 qualifier and has industrial training at Glenmark Pharmaceuticals. He is passionate about academics and research in the field of drug development. 📚💊🧠🔬👨‍🔬

Publication Profile

Google Scholar

Academic Excellence

Dr. Dipanjan Karati is a highly qualified pharmaceutical professional with a strong academic background. He completed his M. Pharm in Pharmaceutical Chemistry from Poona College of Pharmacy, Bharati Vidyapeeth University, Pune, in 2021, securing a first-class distinction with an 8.09 CGPA. Prior to that, he earned his B Pharm from NSHM Knowledge Campus, Kolkata, in 2019, with an outstanding 80.2% (1st class with distinction). Dr. Karati completed his HSC in 2013 with 81.2% and SSC in 2011 with 78.125% from Garh Bhawanipur RP Institution, Howrah. His consistent academic performance highlights his dedication to the pharmaceutical field. 📚💊🎓

Research Project

Dr. Dipanjan Karati’s research focuses on the “In Silico Design, Synthesis, and Evaluation of Novel Schiff Base Congeners as Neurodegenerative and Antimicrobial Agents.” His objective is to design and synthesize innovative pyrimidine derivatives containing a nitrile group and substituted Schiff bases with azomethine groups. These compounds are being explored for their potential in treating neurodegenerative diseases and exhibiting antimicrobial properties. Dr. Karati’s work combines advanced computational techniques and experimental synthesis to develop effective therapeutic agents, aiming to contribute significantly to the fields of neurodegenerative diseases and antimicrobial resistance. 🔬🧠💊🦠💡

Experience

Dr. Dipanjan Karati has an impressive academic and professional background in the pharmaceutical field. He completed his Industrial Training at Glenmark Pharmaceutical Limited from January 9th to 23rd, 2018, gaining valuable industry experience. He served as an Assistant Professor at Gitanjali College of Pharmacy in Lohapur, Birbhum, for one year, contributing to the academic development of students. Currently, Dr. Karati holds the position of Assistant Professor at the School of Pharmacy, TIU, since September 2022, continuing his dedication to education and research. 📚💊👨‍🏫

Achievements and Awards

Dr. Dipanjan Karati achieved a significant milestone by qualifying for the All India Graduate Pharmacy Aptitude Test (GPAT) in 2019, showcasing his dedication and expertise in the field of pharmacy. 🏆📚 This prestigious achievement highlights his academic excellence and potential for contributing to pharmaceutical sciences. 🌟💊 With his strong foundation and passion for research, Dr. Karati is committed to advancing innovations in pharmacy and healthcare. 🚀🔬 His GPAT qualification is a testament to his hard work and determination, inspiring others in the field to strive for academic and professional success. 🌱🎓

Research Focus

Dr. Dipanjan Karati’s research focuses on medicinal chemistry, pharmacognosy, and drug discovery. His studies emphasize exploring bioactive compounds from plants 🌱, such as Ficus racemosa and Zingiber officinale, for their pharmacological properties including anti-inflammatory, anticancer, and antimicrobial activities 🧪🩺. He investigates synthetic scaffolds like pyrazoles and benzimidazoles for designing innovative therapies targeting diseases such as cancer, malaria, and infections 🎯🧬. Dr. Karati also explores bio-responsive polymers for targeted drug delivery and examines natural products like Cordyceps sinensis for therapeutic potential 🍄🔬. His work bridges natural products and modern medicinal approaches, advancing personalized treatments 🌟📖.

Publication Top Notes

Alkylating agents, the road less traversed, changing anticancer therapy

Pyrazole Scaffolds: centrality in anti-inflammatory and antiviral drug design

Exploring the pharmacognostic properties and pharmacological activities of phytocompounds present in Ficus racemosa linn.: A concise review

A molecular insight into pyrazole congeners as antimicrobial, anticancer, and antimalarial agents

Plant Bioactives in the Treatment of Inflammation of Skeletal Muscles: A Molecular Perspective

In-silico investigation and drug likeliness studies of benzimidazole congeners: the new face of innovation

Exploring the phytochemistry, pharmacognostic properties, and pharmacological activities of medically important plant Momordica charantia

AASHAQ HUSSAIN BHAT | Herbal Medicine and Nutraceuticals | Best Researcher Award

Posted on 28/01/202528/01/2025 by sciencefather

AASHAQ HUSSAIN BHAT | Herbal Medicine and Nutraceuticals | Best Researcher Award

Assist. Prof. Dr AASHAQ HUSSAIN BHAT, Chandigarh University, India

🌍 Assistant Professor at Chandigarh University, India, and Adjunct Faculty at Saveetha University, Chennai. Dr. Bhat specializes in entomopathogenic nematodes, ecology, and biocontrol. He completed his PhD in Zoology at Chaudhary Charan Singh University, India, with multiple awards, including the Dr. Motilal Dalela Gold Medal and Early Career Bursary by the Society of Nematologists. With numerous publications and international recognition, Dr. Bhat is an expert in molecular biology, nematode taxonomy, and biocontrol strategies. He is actively engaged in research and is a jury member for science initiatives. 📚🔬

Publication Profile

google scholar

Education

Assist. Prof. Dr. Aashaq Hussain Bhat has an impressive academic journey, with a Ph.D. in Zoology from Chaudhary Charan Singh University, Meerut (2014-2019). He earned his Master of Philosophy (M.Phil.) in Zoology from the same institution in 2012-2013 with 73% marks. His Master’s degree in Zoology (2010-2012) was completed with 75.02% marks. Earlier, Dr. Bhat obtained his Bachelor of Science in Biology from the University of Kashmir (2007-2009) with 67.6% marks. His secondary education was completed at Government Higher Secondary School Hardutoru (2005-2006) with 74%, and high school at the same institution (2003-2004) with 82.4% marks. 📚🎓

Professional position

Dr. Aashaq Hussain Bhat is an accomplished academician and researcher. Currently, he serves as an Assistant Professor at the University Centre for Research and Development, Chandigarh University, Mohali (2023-present) and as an Adjunct Faculty at Saveetha Dental College, Saveetha University, Chennai (2023-present). Dr. Bhat’s previous roles include Postdoctoral Fellow under the Swiss Government Excellence Scholarship at the University of Neuchâtel, Switzerland (2021-2022), Assistant Professor at Government Degree College, Jammu and Kashmir (2020-2021), and Guest Lecturer at Chaudhary Charan Singh University, Meerut (2017-2020). He was also awarded the DST-Inspire Fellowship by the Government of India (2014-2019). 🎓🌍📚

Honors and Awards

Dr. Aashaq Hussain Bhat has received numerous prestigious honors and awards throughout his career. Notably, he was a Jury Member for the World’s First Science Reality Show, Vigyan Ghar Season-2 (2018), and earned the Dr. Motilal Dalela Gold Medal for his research on Steinernema siamkayai in Integrated Pest Management (2018). He has been awarded the Early Career Bursary by the Society of Nematologists (2019), and the Best Oral Presentation Award for his work on Steinernema abbasi (2019). Dr. Bhat was also recognized with the Young Scientist Gold Medal (2015) and MSc Topper Gold Medal (2012). 🏅🎤📚

Member of scientific bodies

Assist. Prof. Dr. Aashaq Hussain Bhat is an esteemed academic and researcher with notable memberships in prominent scientific associations. He is a life member of the Indian Science Congress Association (INCA) 🧑‍🔬, which connects scientists from various disciplines. Dr. Bhat is also an active member of the European Society of Nematologists (ESN) 🪱, contributing to advancements in nematology. Additionally, he is a member of The Society of Chemical Industry (SCI) ⚗️, an organization that fosters innovation and collaboration in the chemical industry. These memberships reflect his dedication to scientific research and his commitment to global scientific progress.

Research Focus

Assoc. Prof. Dr. Aashaq Hussain Bhat’s research primarily revolves around entomopathogenic nematodes and their role in biological pest control. His studies extensively cover Steinernema and Heterorhabditis species, exploring their morphology, molecular characterization, and ecological distribution. Dr. Bhat is also focused on the bacterial symbionts of these nematodes and their potential in controlling agricultural pests. His work includes studies on bacterial zoonoses, antimicrobial resistance, and the broader implications of nematode-bacteria symbiosis in pest management. Through his research, Dr. Bhat contributes significantly to the sustainable agricultural practices and biological control sectors 🌱🐛

Publication Top Notes

Global distribution of entomopathogenic nematodes, Steinernema and Heterorhabditis

Bacterial zoonoses transmitted by household pets and as reservoirs of antimicrobial resistant bacteria

First report and comparative study of Steinernema surkhetense (Rhabditida: Steinernematidae) and its symbiont bacteria from subcontinental India

Study of Steinernema hermaphroditum (Nematoda, Rhabditida), from the West Uttar Pradesh, India

The first report of Xenorhabdus indica from Steinernema pakistanense: co-phylogenetic study suggests co-speciation between X. indica and its steinernematid nematodes

Description of Heterorhabditis bacteriophora (Nematoda: Heterorhabditidae) isolated from hilly areas of Kashmir Valley

Mahshid Malakootian | Cardiovascular Pharmacology | Best Researcher Award

Posted on 27/01/202527/01/2025 by sciencefather

Mahshid Malakootian | Cardiovascular Pharmacology | Best Researcher Award

Assoc. Prof. Dr Mahshid Malakootian, Rajaie cardiovascular medical and research center, Iran

Born on March 21, 1981, in Tehran, Iran, Dr. Mahshid Malakootian is a distinguished molecular geneticist and Associate Professor at Rajaie Cardiovascular Medical & Research Institute, Tehran. A prolific researcher, she specializes in non-coding RNAs, cardiovascular genetics, and bioinformatics. She completed her Ph.D. in Molecular Genetics at Tarbiat Modares University and held postdoctoral fellowships at McGill University and Case Western Reserve University. Dr. Malakootian has published extensively and received numerous accolades, including Best Young Researcher awards. Fluent in English and Persian, she is a dedicated academic, head of the Cardiogenetic Research Center, and an editorial board member. 📚🧬🌍

Publication Profile

google scholar

Academic Excellence

Assoc. Prof. Dr. Mahshid Malakootian is a distinguished expert in molecular genetics and cardiogenetics, contributing significantly to the field. Since 2021, she has served as an Associate Professor at the Cardiogenetic Research Center, Rajaie Cardiovascular Medical and Research Center, Tehran, Iran. 💡 From 2018, she has led the center as its Head, advancing groundbreaking research in cardiovascular genetics. 🧬 Previously, she was an Assistant Professor from 2015 to 2021 and has been an active board member of the Research Deputy since 2015, shaping impactful scientific initiatives. 📚 Her work continues to drive innovation in cardiovascular health. ❤️

Research Experience

Assoc. Prof. Dr. Mahshid Malakootian is an accomplished molecular geneticist with extensive research experience. She pursued her post-doctorate in Experimental Medicine at McGill University, Canada (2016-2017), focusing on PCSK7 RNA regulators 🧬. Previously, she was a post-doctoral fellow at Tarbiat Modares University, Tehran (2014-2015), and a visiting research scholar at Case Western Reserve University, USA (2011-2012) 🔬. Dr. Malakootian earned her Ph.D. (2009-2014) and M.Sc. (2004-2007) in Molecular Genetics at Tarbiat Modares University, where she explored non-coding RNAs and tumorigenesis. Her academic journey began with a B.Sc. in Cellular and Molecular Sciences from the University of Tehran (1999-2003) 🧪.

Honors and Awards

Assoc. Prof. Dr. Mahshid Malakootian is an award-winning researcher recognized for her outstanding contributions in molecular genetics and stem cell technology. 🏆 She has earned accolades such as the “Best Young Researcher” award (2017, 2019) and the “Top Thesis Award” (2014). 🎖 Her pioneering research is supported by multiple grants, including studies on noncoding RNAs and cardiovascular biomarkers. She has discovered and sequenced numerous novel genetic variants, published in GenBank, and co-authored a U.S. patent for miR-her2-1, aiding breast and ovarian cancer diagnostics. 💡📚 A scholar of exceptional caliber, Dr. Malakootian remains a trailblazer in biomedical innovation. 🌟

Professional Societies

Assoc. Prof. Dr. Mahshid Malakootian is an accomplished scientist and an active member of prestigious organizations, including the American Association for Cancer Research (AACR) 🌟, the Iranian Genetics Society (IGS) 🧬, and the Iranian Biotechnology Society 🌿. Her dedication to advancing research is reflected in her role as an editorial board member of the Environmental Health Engineering and Management Journal 📚. With her extensive expertise and contributions, she continues to shape the fields of cancer research, genetics, and biotechnology, fostering innovative solutions for global health challenges 🌍. Dr. Malakootian’s work exemplifies excellence and inspires the scientific community. ✨

Teaching Experience

Associate Professor Dr. Mahshid Malakootian is a distinguished expert in molecular genetics at Shahed University, where she also leads the Advanced Molecular Genetics Lab Course 🧬. Her dedication to education and research has inspired countless students and colleagues. Dr. Malakootian has honed her expertise as a research assistant in Dr. Mowla’s laboratory, contributing to cutting-edge discoveries in molecular genetics 🔬. With a passion for advancing knowledge, she has made significant strides in her field, combining academic excellence with hands-on laboratory experience. Her work continues to shape the future of genetic research and education, making her a respected figure in the scientific community.

Research Focus

Assoc. Prof. Dr. Mahshid Malakootian focuses on cutting-edge research in microRNAs, cardiovascular diseases, and non-coding RNAs in various biological and pathological contexts. Her work explores microRNA roles in cardiovascular development, post-transcriptional regulation, and cancer biology, particularly lung and esophageal tumors. Dr. Malakootian also investigates long non-coding RNAs (lncRNAs), circular RNAs, and their interplay in genetic regulation and disease pathways. Her studies on epigenetics and innovative therapeutic approaches significantly impact cardiovascular health and cancer treatment. 🧬🩺🫀

Publication Top Notes

MicroRNAs: roles in cardiovascular development and disease

Post-transcriptional regulation of PCSK9 by miR-191, miR-222, and miR-224

Two lung development-related microRNAs, miR-134 and miR-187, are differentially expressed in lung tumors

Ciprofloxacin removal from aqueous media by adsorption process: a systematic review and meta-analysis

Pathophysiology, Diagnosis, Treatment, and Genetics of Carpal Tunnel Syndrome: A Review

Linc-ROR and its spliced variants 2 and 4 are significantly up-regulated in esophageal squamous cell carcinoma

Overexpression of BMI1, a polycomb group repressor protein, in bladder tumors: a preliminary report

Differential expression of nucleostemin, a stem cell marker, and its variants in different types of brain tumors

lncRNA PSORS1C3 is regulated by glucocorticoids and fine-tunes OCT4 expression in non-pluripotent cells

Serefnur Ozturk | Clinical Trials | Women Researcher Award

Posted on 25/01/202525/01/2025 by sciencefather

Serefnur Ozturk | Clinical Trials | Women Researcher Award

Prof Serefnur Ozturk, Selcuk University Faculty of Medicine, Turkey

Prof. Şerefnur Öztürk is a leading expert in Neurology and Neurointensive Care, currently serving as the Head of the Neurology Department at Selcuk University, Turkey. She has held prominent roles including Vice Dean of the Faculty of Medicine (1996-2020) and President of the Turkish Neurological Society (2014-2021). With significant international influence, she contributes to the European Academy of Neurology and World Stroke Organization. She has led pivotal projects and trials in stroke and COVID-19-related neurological care. Prof. Öztürk is an acclaimed researcher with numerous influential publications in neurology.

Publication Profile

scopus

Education

Prof. Serefnur Ozturk has an impressive educational background. She began her medical studies at Ankara University Medical Faculty, where she earned her degree between 1980 and 1987. Her academic journey continued with a prestigious NATO Fellowship at Arizona University’s Stroke Center in 1993, further enhancing her expertise. In 1998, she advanced her knowledge in neurology and intensive care at Pittsburgh University, where she studied in their renowned Neurology and Intensive Care Department. These experiences have shaped Prof. Ozturk into a leading figure in her field. 🏥🎓🧠

Internship and Residencies

Prof. Serefnur Ozturk completed her internship at Ankara University Medical Faculty, where she gained valuable hands-on experience. Following this, she pursued her residency at Ankara Numune Research and Education Hospital, further honing her medical skills. Prof. Ozturk’s dedication to her field is reflected in her board certification, earning the Turkish Neurological Board Council Certificate. This certification recognizes her extensive expertise in neurology, solidifying her status as a trusted professional in her area of specialization. Her journey through internships, residencies, and board certification showcases her commitment to excellence. 🏥💉🧑‍⚕️🧠

Experiences

Prof. Serefnur Ozturk holds numerous prestigious leadership roles in neurology. She served as the President of the Turkish Neurological Society from 2014 to 2021 and is currently a member of various important committees, including the European Academy of Neurology (EAN) COVID-19 Task Force and the World Stroke Organization Global Policy Committee. Additionally, she is the Vice President of the European Environmental Neurology Society and has held positions within the World Federation of Neurology (WFN), including President of the Migrant Neurology Specialty Group. Prof. Ozturk is dedicated to advancing stroke care, cerebrovascular diseases prevention, and diversity in neurology. 🧠🌍👩‍⚕️🏥

Projects

Prof. Serefnur Ozturk has played a pivotal role in several major clinical trials and registries. She is the Principal Investigator of the EAN ENERGY COVID-19 Registry and the ENSEMBLE study, showcasing her leadership in critical research. Additionally, Prof. Ozturk serves as the National Coordinator for the Turkish COVID-19 Registry, the ENOS Trial, and TICH-2. Her expertise extends to key studies like the PERFORM Study (Phase III), FACT (Phase IV), and NAVIGATE-ESUS, where she also holds significant leadership positions. Her contributions to clinical research have greatly impacted neurology and stroke care. 🔬🧠🌍💉

Research Focus

Prof. Şerefnur Öztürk’s research focus lies predominantly in neurology, with a special emphasis on the neurological impacts of COVID-19, ischemic stroke, and innovative prognostic tools like the Selcuk Score. Her work is pivotal in advancing the understanding of how pandemics influence neurological care and the management of post-pandemic risks. Additionally, Prof. Öztürk contributes to cutting-edge stroke prevention and rehabilitation technologies, including web-based solutions. Her contributions drive progress in neuro-COVID research, stroke management, and global neurological health policies, showcasing her commitment to improving outcomes for patients worldwide. 🌍🧠💻

Publication Top Notes

The European Academy of Neurology NeuroCOVID-19 Task Force: A lesson for the future

Muscle mass as a modifier of stress response in acute ischemic stroke patients

Management of patients with neurological diseases considering post-pandemic coronavirus disease 2019 (COVID-19) related risks and dangers — An updated European Academy of Neurology consensus statement

The Effect of Tranexamic Acid on Neurosurgical Intervention in Spontaneous Intracerebral Hematoma: Data from 121 Surgically Treated Participants from the Tranexamic Acid in IntraCerebral Hemorrhage-2 Randomized Controlled Trial

General neurology: Current challenges and future implications

Climate Change and Stroke: A Topical Narrative Review